Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes

scientific article

Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...863918E
P356DOI10.1371/JOURNAL.PONE.0063918
P932PMC publication ID3661556
P698PubMed publication ID23717508
P5875ResearchGate publication ID236959593

P2093author name stringArrate Lasa
María P Portillo
Itziar Eseberri
Itziar Churruca
P2860cites workNampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzymeQ24299618
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Resveratrol improves health and survival of mice on a high-calorie dietQ27860950
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alphaQ28274682
Apelin stimulates glucose utilization in normal and obese insulin-resistant miceQ28302298
Apelin, a newly identified adipokine up-regulated by insulin and obesityQ28304725
Changes in white adipose tissue metabolism induced by resveratrol in ratsQ28567175
Effects of the obese gene product on body weight regulation in ob/ob miceQ29617935
Role of leptin in the neuroendocrine response to fastingQ29618866
Discordant protein and mRNA expression in lung adenocarcinomasQ32148037
Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytesQ33389317
Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.Q53432330
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.Q54606528
Bioavailability and Metabolism of ResveratrolQ59158060
Distribution of Resveratrol Metabolites in Liver, Adipose Tissue, and Skeletal Muscle in Rats Fed Different Doses of This PolyphenolQ61875091
Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to ratsQ73139328
Regulation of leptin promoter function by Sp1, C/EBP, and a novel factorQ74278137
Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in miceQ79906474
Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alphaQ80175296
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitusQ84819258
Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoidsQ93942833
Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesityQ33613030
Biological effects of resveratrolQ33841550
Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cellsQ33889566
Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.Q34051374
Inhibition of cancer growth by resveratrol is related to its low bioavailabilityQ34139845
High absorption but very low bioavailability of oral resveratrol in humansQ34343815
Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-LQ34452676
Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetinQ34590988
Mechanisms of regulated unconventional protein secretionQ34915147
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes.Q35226627
Interplay of transcriptomics and proteomicsQ35603060
Pleiotropic mechanisms facilitated by resveratrol and its metabolites.Q35692517
Obesity, hypertension and insulin resistanceQ36114431
Resveratrol: from basic science to the clinicQ36921873
Take a break--resveratrol in action on DNA.Q37049836
Expanding role for the apelin/APJ system in physiopathology.Q37154640
Bioavailability of resveratrolQ37831925
Effect of resveratrol on fat mobilization.Q37831930
Transport, stability, and biological activity of resveratrolQ37831931
Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastropheQ37835313
Apelin, a promising target for type 2 diabetes treatment?Q37996726
Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.Q42716114
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed ratsQ42717892
Effects of resveratrol on the amelioration of insulin resistance in KKAy miceQ42721580
Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processingQ42798067
Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytesQ42809768
TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytesQ42834236
Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric dietQ43112491
Physiological increase in plasma leptin markedly inhibits insulin secretion in vivoQ43555536
Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiaeQ44049342
The inhibitory effect of resveratrol on leptin secretion from rat adipocytes.Q45950969
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic dietQ46310539
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinaseQ46577535
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectadipocyteQ357519
P304page(s)e63918
P577publication date2013-05-22
P1433published inPLOS OneQ564954
P1476titleResveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes
P478volume8

Reverse relations

cites work (P2860)
Q42592297Amino Acid Carbamates As Prodrugs Of Resveratrol
Q38245598Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
Q37426494Combinations of bio-active dietary constituents affect human white adipocyte function in-vitro
Q26765972Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives
Q35108724Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept
Q38521024Dietary polyphenols against metabolic disorders: How far have we progressed in the understanding of the molecular mechanisms of action of these compounds?
Q41779847Doses of Quercetin in the Range of Serum Concentrations Exert Delipidating Effects in 3T3-L1 Preadipocytes by Acting on Different Stages of Adipogenesis, but Not in Mature Adipocytes
Q90052654EFFECT OF HYPEROSIDE ON THE INHIBITION OF ADIPOGENESIS IN 3T3-L1 ADIPOCYTES
Q61796345Effects of Quercetin Metabolites on Triglyceride Metabolism of 3T3-L1 Preadipocytes and Mature Adipocytes
Q38262965Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?
Q35349414Impact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species
Q40824062Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.
Q38231266Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties
Q92150454Natural Compounds as New Cancer Treatments
Q42799566Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation
Q34577984Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line
Q59807405Potential Involvement of Peripheral Leptin/STAT3 Signaling in the Effects of Resveratrol and Its Metabolites on Reducing Body Fat Accumulation
Q41457908Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters.
Q36656592Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression
Q42238830Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes.
Q42368459Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes
Q92743545Resveratrol does not affect leptin while it has regulatory effects on liver glycogen levels in exercised and non-exercised rats
Q58614694Resveratrol, Metabolic Syndrome, and Gut Microbiota
Q48061244Role of sulfotransferases in resveratrol metabolism in human adipocytes
Q41102958Rosmarinic acid suppresses adipogenesis, lipolysis in 3T3-L1 adipocytes, lipopolysaccharide-stimulated tumor necrosis factor-α secretion in macrophages, and inflammatory mediators in 3T3-L1 adipocytes
Q34412057Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds